Stay updated with breaking news from Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) has earned a consensus recommendation of “Moderate Buy” from the fifteen research firms that are presently covering the stock, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 12 month […]
The U.S. Securities and Exchange Commission (SEC) approved a new form of “Cash Management” exemptive order under the Investment Company Act of 1940 (the 1940 Act) on April 3, 2023. The...
Northstar Group Inc. purchased a new position in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) in the 4th quarter, Holdings Channel reports. The institutional investor purchased 5,321 shares of the medical research company’s stock, valued at approximately $263,000. Several other large investors have also recently added to or reduced their stakes in EXAS. […]
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) EVP Sarah Condella sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, April 3rd. The stock was sold at an average price of $67.19, for a total transaction of $67,190.00. Following the sale, the executive vice president now owns 86,692 shares in the […]
Exact Sciences (NASDAQ:EXAS – Get Rating) and RadNet (NASDAQ:RDNT – Get Rating) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk. Volatility and Risk Exact Sciences has a beta of 1.42, suggesting […]